Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    3.00 (4.29%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £188.00m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Portfolio Update

28 Nov 2025 13:34

RNS Number : 4934J
Unicorn AIM VCT PLC
28 November 2025
 

Unicorn AIM VCT PLC

LEI: 21380057QDV7D34E9870

Portfolio Update

 

The Directors of Unicorn AIM VCT plc (the "Company") are pleased to announce that the Company, together with other shareholders of Hasgrove Limited ("Hasgrove"), has entered into an agreement with Castik Capital S.à r.l. ("Castik") in connection with Castik's proposed acquisition of a majority stake in Hasgrove.

 

As part of the transaction, Unicorn AIM VCT plc, together with the former Chairman and members of the executive management team, will realise a portion of their investment for cash and, alongside Castik, will become shareholders in a new holding company established to acquire Hasgrove (the "Newco").

 

Hasgrove is currently the largest holding in the Company's portfolio and was most recently valued at £46.7 million in the Company's Net Asset Value ("NAV") update released as at 31 October 2025. Subject to completion of the transaction, receipt of the cash consideration and the finalisation of valuations, the Board expects the NAV to be materially higher than that reported as at 31 October 2025. In connection with the Transaction, the Company will conduct a fair value review of its interest in Newco and publish an updated NAV as soon as practicable.

 

The Company expects to receive total net proceeds of approximately £87 million from the transaction. Of this amount, approximately £22 million is expected to be settled through the issuance of shares in Newco, with the remaining £65m expected to be received in cash (in each case subject to completion adjustments). The Board will consider whether to declare a special dividend following completion and once final proceeds have been received, with further details (including quantum and timing) to be announced in due course.

 

Unicorn Asset Management Limited ("Unicorn"), the Company's Investment Manager, commented:

 

"Unicorn has been proud to partner with Hasgrove since backing the business at IPO in 2006, providing strategic input and working closely with the leadership team throughout its journey. This transaction delivers another significant realisation for Unicorn AIM VCT plc shareholders, crystallising significant value whilst crucially maintaining exposure to what we believe is a high-quality, cash-generative business with strong growth potential. Having engaged closely with both management and Castik, we are confident this partnership represents the right next step and look forward to working together as Hasgrove enters this exciting new chapter."

 

Tim Woodcock, Chair, Unicorn AIM VCT plc. commented:

 

"The Unicorn team have delivered an excellent result in both realising considerable cash proceeds from the investment for the Company's shareholders, and negotiating a deal which enables the VCT to participate in the future growth of Hasgrove"

 

For further information please contact:

 

Investment Manager:

Unicorn Asset Management Limited

Telephone: 020 7253 0889

Email:info@unicornam.com

 

Company Secretary:

ISCA Administration Services Limited

Telephone: 01392 487056

Email:unicornaimvct@iscaadmin.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUXVLFLEFLXFBL
Date   Source Headline
1st Apr 202510:07 amRNSTotal Voting Rights
31st Mar 202511:15 amRNSOffer for Subscription - Update
18th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 202512:04 pmRNSOffer Update - Overallotment
11th Mar 20251:01 pmRNSDirector/PDMR Shareholding
11th Mar 202511:15 amRNSIssue of Equity under Offer
6th Mar 202511:14 amRNSNet Asset Value(s)
3rd Mar 202510:05 amRNSTotal Voting Rights
21st Feb 20257:00 amRNSDirector/PDMR Shareholding
21st Feb 20257:00 amRNSIssue of Equity
12th Feb 20251:27 pmRNSResult of AGM
4th Feb 20252:39 pmRNSNet Asset Value(s)
3rd Feb 202510:15 amRNSTotal Voting Rights
28th Jan 202512:14 pmRNSPublication of a Prospectus
17th Jan 20256:01 pmRNSTransaction in Own Shares
10th Jan 20253:31 pmRNSNet Asset Value(s)
2nd Jan 202512:51 pmRNSDirector Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
17th Dec 20244:18 pmRNSTransaction in Own Shares
9th Dec 20242:17 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSFinal Results
29th Nov 202411:59 amRNSDividend Declaration
27th Nov 20247:00 amRNSINTENTION TO LAUNCH AN OFFER
5th Nov 20243:05 pmRNSNet Asset Value(s)
18th Oct 202411:05 amRNSNet Asset Value(s)
2nd Oct 202410:30 amRNSDirectorate Change
1st Oct 20249:45 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20249:56 amRNSNet Asset Value(s)
2nd Sep 202410:02 amRNSTotal Voting Rights
16th Aug 20248:58 amRNSTransaction in Own Shares
13th Aug 20249:38 amRNSDirector/PDMR Shareholding
13th Aug 20249:16 amRNSIssue of Equity
6th Aug 20249:31 amRNSNet Asset Value(s)
8th Jul 20242:00 pmRNSNet Asset Value(s)
1st Jul 202410:12 amRNSTotal Voting Rights
20th Jun 20242:25 pmRNSTransaction in Own Shares
7th Jun 20247:00 amRNSNet Asset Value(s)
23rd May 20247:00 amRNSHalf-year Report
8th May 20249:47 amRNSNet Asset Value(s)
8th Apr 20241:46 pmRNSNet Asset Value(s)
2nd Apr 202410:46 amRNSTotal Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 202412:00 pmRNSDirector/PDMR Shareholding
11th Mar 202411:59 amRNSTotal Voting Rights
11th Mar 202411:57 amRNSIssue of Equity
7th Mar 202411:34 amRNSNet Asset Value(s)
1st Mar 202410:54 amRNSTotal Voting Rights
15th Feb 20244:30 pmRNSOffer for Subscription Update
14th Feb 20241:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.